Subscribe To
CNTB / Connect Biopharma stock up more than 40% after trial data
CNTB News
By Zacks Investment Research
October 20, 2023
Has Connect Biopharma Holdings (CNTB) Outpaced Other Medical Stocks This Year?
Here is how Connect Biopharma Holdings Limited Sponsored ADR (CNTB) and Haemonetics (HAE) have performed compared to their sector so far this year. more_horizontal
By Zacks Investment Research
September 15, 2023
Connect Biopharma Holdings Limited Sponsored ADR (CNTB) Upgraded to Buy: What Does It Mean for the Stock?
Connect Biopharma Holdings Limited Sponsored ADR (CNTB) might move higher on growing optimism about its earnings prospects, which is reflected by its more_horizontal
By GlobeNewsWire
August 24, 2023
Connect Biopharma to Participate in Upcoming September Investor Conferences
SAN DIEGO and TAICANG, China, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “C more_horizontal
By Market Watch
March 17, 2023
Connect Biopharma stock up more than 40% after trial data
Connect Biopharma Holdings Ltd. CNTB, -3.51% stock rose more than 40% in the extended session Friday after the company said that analysis of a trial i more_horizontal
By GlobeNewsWire
February 6, 2023
Connect Biopharma to Present at SVB Securities Global Biopharma Conference and Participate in BioCom California
SAN DIEGO and TAICANG, SUZHOU, China, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB), a global clinical-stage bio more_horizontal
By Benzinga
May 4, 2022
Connect Biopharma Stock Plunges As Ulcerative Colitis Candidate Flunks In Mid-Stage Study
Connect Biopharma Holdings Limited (NASDAQ: CNTB) announced topline results at 12 weeks from its Phase 2 trial for CBP-307 (CBP-307CN002) for ulcer more_horizontal
By GlobeNewsWire
February 9, 2022
Connect Biopharma to Participate at the SVB Leerink 11th Annual Global Healthcare Conference
SAN DIEGO and TAICANG, China, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) ("Connect Biopharma" or the “Compa more_horizontal
By GlobeNewsWire
February 9, 2022
Connect Biopharma to Participate at the SVB Leerink 11th Annual Global Healthcare Conference
SAN DIEGO and TAICANG, China, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) ("Connect Biopharma" or the “Compa more_horizontal